Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038002 (
splenomegaly
)
9,873
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The ability of strains and fractions of killed propionibacteria suspensions to produce chronic rat ear inflammation after intradermal injection of 70-micrograms aliquots was highly correlated with production of
splenomegaly
in the mouse after i.p. injection of 1.4 mg Propionibacterium acnes strains CN 6134,
VPI
0009, ATCC 11828, and UCLA SC and N1 produced a 2- to 3-fold increase in rat ear thickness and a 5- to 7-fold increase in mouse spleen weight 15 days post injection. In contrast P. granulosum CN 5888, P. acnes UCLA 6S and periodated, acetylated, or 12-h cultures of
VPI
0009 were inactive or weakly active as stimulators of chronic ear inflammation and
splenomegaly
. Active strains produced in the rat ear a transepidermal elimination response characterized by follicular encapsulation and the formation of secondary comedones. These effects correlated with persistence of phagocytized bacteria within macrophages. Furthermore, when rats were first immunized and then challenged with active strains of P. acnes, an increased sensitivity to low doses of P. acnes and a chronic exacerbation of inflammation was observed.
...
PMID:Acne-like chronic inflammatory activity of Propionibacterium acnes preparations in an animal model: correlation with ability to stimulate the reticuloendothelial system. 316 57
Stationary-phase (48 h) cells of Propionibacterium acnes
VPI
0009, a potent stimulator of the reticuloendothelial system, persist unchanged within phagocytes for at least 24 h after ingestion. In contrast, exponential-phase (12 h) cells of the same strain (which do not induce
splenomegaly
) are extensively degraded within 5 h of phagocytosis. Suspensions of P. granulosum
VPI
6500, which fails to induce
splenomegaly
in mice, also show considerable degradation after phagocytosis. Stationary-phase cells of strain
VPI
0009 treated with sodium metaperiodate or with trichloroacetic acid, although without ability to induce
splenomegaly
, resist destruction almost as well as untreated vaccines. However, bacteria inactivated by acetic anhydride show about 50% breakdown in 24 h.
...
PMID:Fate of vaccines of Propionibacterium acnes after phagocytosis by murine macrophages. 629 96
The surface of Propionibacterium acnes,
VPI
0009, was studied using microelectrophoresis following chemical treatments intended to modify specific charged groups. The effect of specific modifications on ability of cells to induce
splenomegaly
, an indicator of stimulation of the reticuloendothelial system, was also determined. There was little difference between pH mobility curves of P. acnes
VPI
0009 and other strains of propionibacteria which were not able to stimulate the reticuloendothelial system. Amino and carboxyl groups were found to be the sole ionizable groups at the cell surface and modification of these groups caused a substantial decrease in the ability of cells to stimulate the reticuloendothelial system. No phosphate groups were detected. Evidence for two types of amino groups was found: one type was present on protein moieties and their modification did not affect ability to stimulate the reticuloendothelial system, whereas modification of the other type, which was present on carbohydrate moieties, caused a loss of ability to stimulate the reticuloendothelial system. Mild oxidation with sodium metaperiodate caused abolition of reticuloendothelial system stimulation, but had no effect on surface charged groups, indicating it was acting on the unsubstituted linkages of sugar residues. Treatments with strong acids caused abolition of ability to stimulate the reticuloendothelial system and this was accompanied by release of polysaccharide material.
...
PMID:The cell surface of Propionibacterium acnes: effect of specific chemical modifications on the ability of vaccines to produce splenomegaly in mice. 709 18